Clinical trial
Study of the Genome, Gut Metagenome and Lifestyle of Patients With Incident Type 2 Diabetes Mellitus
NCT04113239 is registered in ClinicalTrials.gov with Atlas Biomed as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study of the Genome, Gut Metagenome and Lifestyle of Patients With Incident Type 2 Diabetes Mellitus
- Lead sponsor
- Atlas Biomed
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 27, 2019
- Completion date
- November 25, 2021
- Enrollment
- 200 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
diabetes mellitus, type 2, genetic predisposition, metagenome